Effects of fibrin on the enhanced activation of plasminogen by urokinase and tissue plasminogen activator: role of cross-link
- PMID: 3083529
- DOI: 10.1016/0049-3848(86)90357-9
Effects of fibrin on the enhanced activation of plasminogen by urokinase and tissue plasminogen activator: role of cross-link
Abstract
When human plasma was activated by urokinase (UK) in the presence of thrombin, thrombin plus Ca++, Ca++ or in their absence and the plasmin activity was measured by the hydrolysis of S-2251, plasmin activity was higher in the presence of cross-linked or non cross-linked plasma clot. The results of similar experiments utilizing plasma after severe exercise indicated that the hydrolysis of S-2251 by plasma containing tissue plasminogen activator (t-PA) was also higher in cross-linked or non cross-linked plasma clot. Fibrinolysis was faster in thrombin-induced plasma clot, but was later shown significantly in plasma clot induced by thrombin and Ca++, whereas practically no fibrinogenolysis was shown in plasma. When Glu-plasminogen (Glu-plg) was activated by UK in the presence of cross-linked or non cross-linked fibrin and alpha 2 antiplasmin (alpha 2AP), fibrinolysis was faster in cross-linked fibrin than non cross-linked fibrin in the presence of alpha 2AP. No fibrinogenolysis was shown either. Plasmin activity measured by the hydrolysis of S-2251 was also higher in cross-linked or non cross-linked fibrin than in fibrinogen in the presence of alpha 2AP. These results indicate that enhanced activation of Glu-plg by UK or t-PA in the presence of fibrin was a more significant event than the inactivation of plasmin in the plasma clot or purified clot by alpha 2AP cross-linked to fibrin.
Similar articles
-
Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.Thromb Res. 1987 Feb 15;45(4):371-81. doi: 10.1016/0049-3848(87)90226-x. Thromb Res. 1987. PMID: 2437668
-
Autoradiographic and immunoblotting analyses of the activation pathways of plasminogen by urokinase and tissue plasminogen activator in the plasma or clotted plasma.Thromb Res. 1988 Jan 15;49(2):193-204. doi: 10.1016/0049-3848(88)90213-7. Thromb Res. 1988. PMID: 3129815
-
Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.J Clin Invest. 1988 Mar;81(3):853-9. doi: 10.1172/JCI113394. J Clin Invest. 1988. PMID: 2963831 Free PMC article.
-
Physiology of plasminogen: with special reference to activation and degradation.Haemostasis. 1988;18 Suppl 1:25-35. doi: 10.1159/000215834. Haemostasis. 1988. PMID: 3280423 Review.
-
New approaches to thrombolytic therapy.Arteriosclerosis. 1984 Nov-Dec;4(6):579-85. doi: 10.1161/01.atv.4.6.579. Arteriosclerosis. 1984. PMID: 6439177 Review.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous